Duquesne Family Office LLC
SuperinvestorDuquesne Family Office
- SEC CIK
- 0001536411
- Manager
- Stanley Druckenmiller
- Style
- Macro
TEVA holding history
TEVA PHARMACEUTICAL INDUSTRIES LTD
Every 13F filing in which Duquesne Family Office reported holding TEVA, plus the quarters it sold out. Changes compare share counts with the previous calendar quarter.
TEVA overviewAll 13F holders of TEVAFull portfolio
| Quarter | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Q2 2026 | 624,999 | $21.18M | 0.49% | −1,752,286−73.7% | Reduced |
| Q1 2026 | 2,377,285 | $71.6M | 2.44% | −3,497,585−59.5% | Reduced |
| Q4 2025 | 5,874,870 | $183.36M | 4.34% | −10,719,065−64.6% | Reduced |
| Q3 2025 | 16,593,935 | $335.2M | 8.53% | +625,000+3.9% | Added |
| Q2 2025 | 15,968,935 | $267.64M | 6.84% | +1,089,185+7.3% | Added |
| Q1 2025 | 14,879,750 | $228.7M | 7.67% | +5,882,350+65.4% | Added |
| Q4 2024 | 8,997,400 | $198.3M | 5.58% | +7,569,450+530.1% | Added |
| Q3 2024 | 1,427,950 | $25.73M | 0.90% | +1,427,950 | New |